Skip to main content

Table 1 Distribution of disease severity, anti-ACE2 autoantibody and CR antibody positive rate in COVID-19 patients with vaccination (Vac) or without (UnVac)

From: Enhancement of NETosis by ACE2-cross-reactive anti-SARS-CoV-2 RBD antibodies in patients with COVID-19

Demographic

UnVac (n = 31)

Vac (n = 89)

P valuea

Disease severity

  

 < 0.0001

 Mild

4 (12.9%)

63 (70.8%)

 

  Positive for Anti-ACE2 autoAb

1 (25%)

7 (11.1%)

ns

  Positive for CR Ab

0

1 (1.6%)

ns

 Moderate/Severe

27 (87.1%)

26 (29.2%)

 

  Positive for Anti-ACE2 autoAb

18 (66.7%)

7 (26.9%)

0.058

  Positive for CR Ab

9 (33.3%)

1 (3.8%)

0.011

  1. Abbreviation: ns not significant
  2. aThe Fisher exact test was used to determine the P values